by Margaret Hellard, Roger Chou, Jacinto Amandua et al.
World Health Organization, February 2017
Testing and diagnosis of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations.